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PRACTICAL PEARLS: Vitamin D Screening 
 
INTRODUCTION  Screening for Vitamin D deficiency (VDD) should be selective: there is no evidence 
that universal screening is warranted.  
 Children at risk for VDD include breast-fed infants, kids with obesity, 
malabsorption syndromes, and chronic glucocorticoid, anticonvulsant, antifungal, 
and antiretroviral medications.  





BY PRIMARY CARE  
 Measure serum 25-OH-D. It is NOT necessary to measure Calcium or PTH; 1,25-
OH-D should NOT be measured.  
 25-OH-D >20 ng/mL is sufficient. This target is recommended by the IOM, 
Pediatric Endocrine Society and the European Society for Pediatric 
Gastroenterology, Hepatology and Nutrition. 
 If 25-OH-D levels are <20 ng/mL, repeat with Ca, P and PTH levels. Significant VDD 
is associated with elevated PTH levels; severe VDD may also be associated with 
low Ca and P levels.  
 Treatment consists of vitamin D2 or D3 2000 IU/d or 50 000 IU/week for 6 weeks 
followed by a maintenance dose 400-1000 IU/d in infants and toddlers or 600-
1000 IU/d in children and teens. 25-OH-D should be re-measured after therapy. 
 
WHEN TO REFER  Severe VDD (<10) with hypocalcemia or rickets; VDD associated with extremely 
elevated PTH levels; VDD refractory to therapy after 12 weeks   
 
HOW TO REFER 
 
 (413) 794-KIDS: Pediatric Endocrinology  





 Comprehensive evaluation and treatment  
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